Dospěl totiž k závěru, že ze zákona o silničním provozu nevyplývá povinnost cyklisty užít stezku pro chodce a cyklisty. Cyklisté jsou podle NSS plnohodnotnými účastníky silničního provozu a náleží jim veškerá práva a povinnosti z toho vyplývající…..
https://t.co/ny6Ox9PSVb
Severe AS is defined as:
aortic valve area (AVA) & indexed AVA being (<1.0 cm2 and <0.6 cm2/m2, respectively)
with a peak aortic jet velocity and mean transvalvular pressure gradient being (>4 m/s and >40 mmHg, respectively) on #echofirst
But
For twenty years our practice has been conditioned by this meta-analysis, then somehow indirectly denied by studies such as STITCH and REVIVED. Does it still make sense to look for viable myocardium by means of tests such as SPECT, PET or dobutamine echocardiography, in 2023?
J'en ai fait la proposition au Parlement européen le 9 mai dernier, aujourd’hui nous y sommes : pour un dialogue stratégique à l'échelle du continent, une Communauté politique européenne est née. 44 Nations portent ensemble un message d’unité.
💥My top 10 learning points from the #ESCCongress 2022💥
A thread for cardiologists/general physicians
1) Addition of IV acetazolamide to IV furosemide in AHF results in 46% higher incidence of successful decongestion after 3 days
EVIDENCE: ADVOR https://t.co/wgDeXkRAQe
❤️🩹 optimální způsob předléčby pomocí P2Y12i u IM pacientů … For Best Results in ACS PCI: Treat Upstream With P2Y12 Inhibitors - American College of Cardiology https://t.co/6GpZAIj0Tt #Cardiotwitter#kardiotwitter
RECOVERY Publication: ASPIRIN
(a widely used anti-platelet treatment in other settings)
14 892 patients hospitalised with COVID-19.
No impact on mortality.
Small improvement in hospital stay.
No impact on need for mechanical ventilation
6 more bleeds. 6 fewer thromboses (clots)
RECOVERY Publication: ASPIRIN
(a widely used anti-platelet treatment in other settings)
14 892 patients hospitalised with COVID-19.
No impact on mortality.
Small improvement in hospital stay.
No impact on need for mechanical ventilation
6 more bleeds. 6 fewer thromboses (clots)
PRAGUE-17 three-year outcomes: left atrial appendage closure (LAAC) non-inferior to NOAC in preventing major CV and neurological events thru 3.5 years in high-risk AFib patients, less bleeding with LAAC. Download slides here https://t.co/uUedXdLTcd #TCT2021
In stable CAD patients with moderate or severe myocardial ischaemia enrolled in ISCHEMIA, an initial INV treatment strategy prevented neither the first event nor the total events more effectively than an initial CON strategy. https://t.co/PjzZPZQ8wi